Beneficial Efficacy of Carperitide in Patients with Acute Decompensated Heart Failure
Phase 4
- Conditions
- Acute heart failure
- Registration Number
- JPRN-jRCTs031180090
- Lead Sponsor
- Ikari Yuji
- Brief Summary
This study suggested the safety and efficacy of low dose Carperitide in patients with acute heart failure. In addition, to treat effectively with using Carperitide, measurement of baseline ANP levels and focusing on the presence of HFpEF and AF would be necessary.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 162
Inclusion Criteria
Hospitalized patients with acute heart failure and treated by administration of Carperitide.
Exclusion Criteria
1 Under 20 years old
2 With ventricular assist device
3 Cardiogenic shock; treated by catecholamine
4 Dehydration
5 Dialysis
6 Allergy to Carperitide
7 Pregnancy, lactating woman
8 Acute myocardial infarction
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method rinary volume for 6 hours after administration of Carperitide
- Secondary Outcome Measures
Name Time Method 1 Total urinary volume<br>2 Acute kidney injury<br>3 Results of blood examination<br>4 Usage or dosage of diuresis<br>5 Symptoms<br>6 Physical findings of heart failure<br>7 Admission term<br>8 Any adverse events for patients